Regular salmeterol vs placebo
All‐cause mortality ‐ adults and adolescents · patients with chronic asthma
Regular salmeterol showed no clear difference in all‐cause mortality ‐ adults and adolescents compared with placebo (moderate certainty).
1 finding from 1 review
- Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes onlyOR 1.33 [0.85, 2.08]10 studies · 29128 participantsModerate